By: Sally Seck
With increasing research into the medicinal properties of marijuana comes an increasingly long list of conditions it can treat.
New research coming out of the Salk Institute for Biological Studies focuses on how THC impacts the beta amyloid protein prevalent in the brains of those with Alzheimer's disease. This protein is responsible for the "nerve cell death" that causes the symptoms of dementia. The study found that cannabinoids not only remove the beta amyloid proteins and reduce the inflammation that occurs in the brain as a result of their growth, but actually prevent their growth.
According to the Institute, "while these exploratory studies were conducted in neurons grown in the laboratory, they may offer insight into the role of inflammation in Alzheimer's disease and could provide clues to developing novel therapeutics for the disorder."
This theory will need to be tested in clinical trials, but it is exciting to see that marijuana may be the answer to Alzheimer's disease, as scientists have never been able to identify a cause or a cure for the over 5 million people in America alone who have the disease.